Twist Bioscience Corporation

NASDAQ:TWST

Medical - Diagnostics & Research

Healthcare
$116.35 +2.59%

+$2.15 today

Market cap
$7.66B
Beta
2.21
P/E (TTM)
-64.5
EPS (TTM)
-$1.32
52W Low $23.30High $88.46

Volume 2.23M

Average 1.53M

TWST Other Non-current Liabilities

Long-term obligations not reported separately, such as lease or pension liabilities.

Twist Bioscience CorporationNASDAQ: TWST

Other Non-current Liabilities · Q4 FY2026 · quarter ended Sep 2026

Other non-current liabilities turns positive

Q4 FY2026 other non-current liabilities was $21.45M, compared with -$46M a year earlier. Over 3 fiscal years it compounded at +256.1% a year.

Context

  • Other non-current liabilities amounted to 1.9% of total assets at the end of Q4 FY2026, down 5.3 pp from a year earlier.
  • Other non-current liabilities increased in 1 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether other non-current liabilities keeps rising in the next quarterly balance sheet after a +146.6% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2026
$21.45M-0.2% QoQ
Last fiscal yearSep 2026
$21.45M+146.6% YoY
Year agoSep 2025
-$46M+146.6% since
Other Non-current Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+146.6%——
1 year+146.6%——
3-year CAGR+256.1%——
5-year CAGR——
10-year CAGR——

Other Non-current Liabilities history

USD · from the balance sheet

Latest · FY2026
21.45M USD
Year-over-year change
+146.6%
4-year CAGR
+334.8%

Other Non-current Liabilities vs competitors

How TWST compares with its peers on the latest reported figures

  • TWST's Sep 2026 other non-current liabilities of $21.45M is the highest of the 2 companies compared; the peer median is $17.09M.
  • Its year-over-year change of +146.6% is the highest of 2, against a peer median of -27.4%.
  • Other non-current liabilities amounts to 1.9% of total assets for TWST, versus a peer median of 0.6%.
TWST Competitors Peer median
Other Non-current Liabilities for TWST and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
TWSTTwist Bioscience CorporationSep 2026$21.45M +146.6%+256.1%1.9%
RGENRepligen CorporationJun 2026$17.09M -27.4%-37.4%0.6%
Peer median (excluding TWST) $17.09M-27.4%-37.4%0.6%

Competitors are the stored peer set for TWST. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
FY2026
Sep 2026
Cash & Equivalents378.69M286.47M226.32M183.05M533.99M
Short-term Investments126.28M49.94M50.08M49.39M47.92M
Net Receivables40.29M44.06M34.9M57.32M70.19M
Inventory39.31M32.06M24.08M28.31M46.41M
Other Current Assets011.72M11.4M14.9M38.71M
Total Current Assets596.48M424.26M346.78M332.97M737.22M
Property, Plant & Equipment (Net)214.39M203.36M161.35M151.66M191.6M
Goodwill85.81M85.81M85.81M82.2M82.2M
Intangible Assets59.74M54.48M14.48M13.43M34.16M
Long-term Investments02.81M1.53M54.34M68.09M
Tax Assets00000
Other Non-current Assets4.96M5.68M4.38M7.28M8.54M
Total Non-current Assets364.9M352.15M267.55M308.9M384.58M
Total Assets961.38M776.4M614.32M641.86M1.12B
Account Payables20.09M14.05M1.63M11.09M24.85M
Short-term Debt00013.82M0
Tax Payables3.66M4.37M2.73M00
Deferred Revenue3.48M3M2.13M6.88M0
Other Current Liabilities39.62M26.25M34.61M23.78M54.19M
Total Current Liabilities90.66M73.32M71.01M91.41M125.81M
Long-term Debt00061.75M0
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities60K475K407K(46M)21.45M
Total Non-current Liabilities81.33M79.65M70.63M77.5M107.98M
Total Liabilities171.99M152.97M141.63M168.9M233.79M
Common Stock00001K
Retained Earnings(828.42M)(1.03B)(1.24B)(1.32B)(1.45B)
Accumulated OCI(1.84M)(756K)(522K)(627K)(680K)
Other Stockholders Equity00002.34B
Minority Interest00000
Total Equity789.39M623.43M472.69M472.96M888.02M
Total Debt94.91M94.07M85.03M137.32M94.99M
Net Debt(283.78M)(192.4M)(141.29M)(45.73M)(439.01M)

Twist Bioscience Corporation

NASDAQ:TWST

Intrinsic Alpha fair value

Locked

Current Price

$116.35

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.